These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10030500)

  • 41. New pediatric dosage rules: information and testing.
    Feeg VD
    Pediatr Nurs; 1998; 24(6):518, 613. PubMed ID: 10085992
    [No Abstract]   [Full Text] [Related]  

  • 42. FDA eases medication guide distribution requirements.
    Traynor K
    Am J Health Syst Pharm; 2011 Apr; 68(8):649-50. PubMed ID: 21460167
    [No Abstract]   [Full Text] [Related]  

  • 43. Regulation of dietary supplements in the United States: understanding the dietary supplement health and education act.
    Hoffman FA
    Clin Obstet Gynecol; 2001 Dec; 44(4):780-8. PubMed ID: 11600859
    [No Abstract]   [Full Text] [Related]  

  • 44. FDA Modernization Act: implications for oncology.
    Morris L
    Oncology (Williston Park); 1998 Nov; 12(11A):139-41. PubMed ID: 10028506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FDA delays proposal on patient drug information.
    Am J Health Syst Pharm; 1995 Feb; 52(4):355-6. PubMed ID: 7757853
    [No Abstract]   [Full Text] [Related]  

  • 46. Off-label or off-limits?
    Ratner M; Gura T
    Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236
    [No Abstract]   [Full Text] [Related]  

  • 47. Another popular painkiller gets the government's hook.
    Querna E
    US News World Rep; 2005 Apr; 138(14):47. PubMed ID: 15839129
    [No Abstract]   [Full Text] [Related]  

  • 48. Drug safety in the digital age.
    Hwang TJ; Bourgeois FT; Seeger JD
    N Engl J Med; 2014 Jun; 370(26):2460-2. PubMed ID: 24963564
    [No Abstract]   [Full Text] [Related]  

  • 49. Proposed NSAID package insert labeling.
    Food and Drug Administration U.S. Public Health Service
    J Pain Palliat Care Pharmacother; 2006; 20(1):49-55. PubMed ID: 16687359
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pros and cons of off-label promotion investigations and prosecutions.
    Loucks MK
    Food Drug Law J; 2006; 61(3):577-83. PubMed ID: 16989041
    [No Abstract]   [Full Text] [Related]  

  • 51. Off-label prescribing and the standard of care.
    Johnson LJ
    Med Econ; 2001 Aug; 78(16):97. PubMed ID: 11550443
    [No Abstract]   [Full Text] [Related]  

  • 52. [Drug counterfeiting and counter measures. Study by the Hungarian National Alliance Against Drug Counterfeiting].
    Psychiatr Hung; 2009; 24(3):205-14. PubMed ID: 20017282
    [No Abstract]   [Full Text] [Related]  

  • 53. Regulators demand leaner, succinct drug labeling.
    Young D
    Am J Health Syst Pharm; 2006 Jun; 63(12):1111-2. PubMed ID: 16754732
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical trial transparency--antidote to weaker off-label-promotion rules?
    Outterson K
    N Engl J Med; 2014 Jul; 371(1):1-3. PubMed ID: 24988551
    [No Abstract]   [Full Text] [Related]  

  • 55. Direct-to-consumer prescription drug advertising.
    Terzian TV
    Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573
    [No Abstract]   [Full Text] [Related]  

  • 56. Drug and device litigation in the 21st century.
    Svitak LS; Goss PJ
    Spec Law Dig Health Care Law; 2001 Nov; (271):9-36. PubMed ID: 11802352
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacists' role in facilitating evidence-based prescribing for unlabeled use of medications.
    Macaulay TE; Cook AM; Fink JL; Rapp RP; Vincent WR
    Am J Health Syst Pharm; 2009 Oct; 66(19):1735-9. PubMed ID: 19767380
    [No Abstract]   [Full Text] [Related]  

  • 58. The First Amendment and federal court deference to the Food and Drug Administration: The Times They Are A-Changin'.
    Basile EM; Gross M
    Food Drug Law J; 2004; 59(1):31-44. PubMed ID: 15190924
    [No Abstract]   [Full Text] [Related]  

  • 59. Adverse-drug-reaction monitoring.
    Faich GA
    N Engl J Med; 1986 Jun; 314(24):1589-92. PubMed ID: 3713757
    [No Abstract]   [Full Text] [Related]  

  • 60. Vioxx may go back on sale after scraping past FDA panel.
    Wadman M
    Nature; 2005 Feb; 433(7028):790. PubMed ID: 15729304
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.